These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Hyperkalemia is a potentially serious condition that may be associated with numerous pathophysiological conditions. Clinically significant hyperkalemia reduces membrane excitability and disturbs ...

Vitamin K supplementation may serve as a nocturnal leg cramps treatment reducing frequency, intensity, and duration in older ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

The consequences of primary aldosteronism mainly result from the activation of the mineralocorticoid receptor. Two of these ...

Other than having high blood pressure, I am healthy, eat a Mediterranean-style diet, and exercise most days. Since 2021, I have been taking one tab of amlodipine/valsartan daily with blood pressure ...

(PV) treatment approaches include both therapeutic phlebotomy and medications like hydroxyurea or interferon to control blood counts, with treatment selection based on individual risk factors and ...

WILMINGTON, Del. - The U.S. Food and Drug Administration (FDA) has granted approval to AstraZeneca (NASDAQ:AZN)'s CALQUENCE® ...

Elevated blood pressure is the most important risk factor for cardiovascular disease. Numerous clinical practice guidelines ...